屈臣氏去年健康類別產品銷售額按年增長11%
屈臣氏集團公布,去年健康類別產品銷售額按年增長11%,維他命和營養補充劑銷售額按年增長12%;期內購買保健產品顧客達10億人次,購買保健產品的顧客光顧集團旗下店舖的次數平均每年超過10次,消費額亦較一般顧客高出近80%。
屈臣氏顧客體驗研究團隊所作的全球健康調查結果顯示,全球10個市場健康水平中以荷蘭排名最高,其次為新加坡、英國、菲律賓、馬來西亞、中國內地、烏克蘭、台灣及香港,泰國則排名最低。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.